Polycystic Ovary Syndrome

"Polycystic Ovary Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.

Descriptor ID	D011085
MeSH Number(s)	C04.182.612.765 C13.351.500.056.630.580.765 C19.391.630.580.765
Concept/Terms	Polycystic Ovary Syndrome Polycystic Ovary Syndrome Ovary Syndrome, Polycystic Syndrome, Polycystic Ovary Stein-Leventhal Syndrome Stein Leventhal Syndrome Syndrome, Stein-Leventhal Sclerocystic Ovarian Degeneration Ovarian Degeneration, Sclerocystic Sclerocystic Ovary Syndrome Polycystic Ovarian Syndrome Ovarian Syndrome, Polycystic Polycystic Ovary Syndrome 1 Sclerocystic Ovaries Sclerocystic Ovaries Ovary, Sclerocystic Sclerocystic Ovary

Below are MeSH descriptors whose meaning is more general than "Polycystic Ovary Syndrome".

Diseases [C]
Neoplasms [C04]
Cysts [C04.182]
Ovarian Cysts [C04.182.612]
Polycystic Ovary Syndrome [C04.182.612.765]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Genital Diseases, Female [C13.351.500]
Adnexal Diseases [C13.351.500.056]
Ovarian Diseases [C13.351.500.056.630]
Ovarian Cysts [C13.351.500.056.630.580]
Polycystic Ovary Syndrome [C13.351.500.056.630.580.765]
Endocrine System Diseases [C19]
Gonadal Disorders [C19.391]
Ovarian Diseases [C19.391.630]
Ovarian Cysts [C19.391.630.580]
Polycystic Ovary Syndrome [C19.391.630.580.765]

Below are MeSH descriptors whose meaning is related to "Polycystic Ovary Syndrome".

Below are MeSH descriptors whose meaning is more specific than "Polycystic Ovary Syndrome".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Polycystic Ovary Syndrome" by people in this website by year, and whether "Polycystic Ovary Syndrome" was a major or minor topic of these publications.

Bar chart showing 19 publications over 15 distinct years, with a maximum of 2 publications in 2001 and 2017 and 2021 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
2000	1	0	1
2001	1	1	2
2004	1	0	1
2005	1	0	1
2009	1	0	1
2011	1	0	1
2012	0	1	1
2014	1	0	1
2017	1	1	2
2019	1	0	1
2020	1	0	1
2021	2	0	2
2022	2	0	2
2023	1	0	1

Below are the most recent publications written about "Polycystic Ovary Syndrome" by people in Profiles.

Sama SR, Gore R, Bauer AZ, Garber L, Rosiello R, Sundaresan D, McDonald A, Kriebel D. Targeting patients for early COVID-19 therapy; Pre-infection metabolic dysfunction, polycystic ovary syndrome and risk of severe disease in patients under 65: A Massachusetts community-based observational study. PLoS One. 2023; 18(6):e0287430.

View in: PubMed
Riepsamen AH, Donoghoe MW, Indran IR, Hechtman L, Robertson DM, Gilchrist RB, Ledger WL, Yong EL. Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf). 2023 04; 98(4):567-577.

View in: PubMed
Joshi A, Aluko A, Styer AK, Young BC, Johnson KM, Hacker MR, Modest AM. PCOS and the risk of pre-eclampsia. Reprod Biomed Online. 2022 11; 45(5):961-969.

View in: PubMed
Kovell LC, Juraschek SP, Michos ED. Hypertension in Young Women: Implications of the Polycystic Ovary Syndrome and Opportunities for Prevention and Further Research. J Clin Endocrinol Metab. 2021 08 18; 106(9):e3775-e3777.

View in: PubMed
Vagios S, Sacha CR, Hammer KC, Dimitriadis I, James KE, Bormann CL, Souter I. Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-M?llerian hormone levels. J Assist Reprod Genet. 2021 Jul; 38(7):1827-1833.

View in: PubMed
Vagios S, James KE, Sacha CR, Hsu JY, Dimitriadis I, Bormann CL, Souter I. A patient-specific model combining antim?llerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders. Fertil Steril. 2021 01; 115(1):229-237.

View in: PubMed
Riepsamen AH, Chan K, Lien S, Sweeten P, Donoghoe MW, Walker G, Fraison EHJ, Stocker WA, Walton KL, Harrison CA, Ledger WL, Robertson DM, Gilchrist RB. Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 During IVF and in Women With Reproductive Pathologies. Endocrinology. 2019 10 01; 160(10):2298-2313.

View in: PubMed
Jalnapurkar I, Findley JC. A case of repeated mixed mood episodes with psychotic symptoms associated with the premenstrual period in a patient with polycystic ovarian syndrome. Gynecol Endocrinol. 2018 Jun; 34(6):467-469.

View in: PubMed
Sahay M, Kalra S, Tiwaskar M, Ghosh S, Badani R, Bantwal G, Das AK, Dhorepatil B, Jeloka T, Khandelwal D, Nadkar MY, Saboo B, Sahay R, Unnikrishnan AG, Aggarwal S, Agrawal N, Bajaj S, Baruah MP, Chadha M, Das S, Dhamija P, Julka S, Mehta P, Shah SN, Sharma B, Muruganathan A. Indian College of Physicians Position Statement on Anemia in Metabolic Syndrome. J Assoc Physicians India. 2017 Jun; 65(6):60-73.

View in: PubMed
Merkin SS, Phy JL, Sites CK, Yang D. Environmental determinants of?polycystic ovary syndrome. Fertil Steril. 2016 07; 106(1):16-24.

View in: PubMed

People

Explore

Similar Concepts

Top Journals